Company / Current Assets per Share
Tvardi Therapeutics, Inc. Current Assets per Share History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets per Share
$9.65
FY2024
5-year range
$2.16 / $9.65
FY2020-FY2024
Trend
+347.1%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Assets per Share changed +347% YoY in FY2024, a notable deviation from the 9-year average annual change of +36%.
Based on SEC 10-K filings.
9.65 in FY2024 with a 5-year CAGR of +18.2%.
Improved from $3.16 to $9.65 over the past 2 years.
Current Assets per Share over time
Growth rates
- 3-Year CAGR
- +40.6%
- 5-Year CAGR
- +18.2%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2024, current assets per share increased 347.1% year-over-year.
- Lowest current assets per share in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score -6.41 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $9.65 | +347.1% |
| FY2023 | $2.16 | -31.6% |
| FY2022 | $3.16 | -9.1% |
| FY2021 | $3.47 | -16.8% |
| FY2020 | $4.18 | -0.3% |
| FY2019 | $4.19 | -18.6% |
| FY2018 | $5.15 | +47.8% |
| FY2017 | $3.48 | +54.5% |
| FY2016 | $2.25 | -52.8% |
| FY2015 | $4.78 | -61.5% |
As of FY2024 · SEC 10-K · Updated Jun 28, 2026